betalin therapeutics ltd
General Data
Reg Number
515274272
Sector
Biomed
Established
2015
No. of Employees
12
Stage
R&D
Additional Funding
0
Technology
Betalin is developing a micro-pancreas to liberate diabetic patients from their daily insulin dependency. It responds to the patient’s blood glucose levels by releasing controlled therapeutic levels of insulin for at least a year.
Targeted Customers
Insulin dependent diabetes patients, Medical service providers.
Management personnel
Winning details
Route name
Winning year
Increasing participation of Israeli industrial corporations in the European Horizon program
Increasing participation of Israeli industrial corporations in the European Horizon program
2024
Increasing participation of Israeli industrial corporations in the European Horizon program
Increasing participation of Israeli industrial corporations in the European Horizon program
2024